ADVFN - Advanced Financial Network.
HOME» NYSE » P » PKI Stock Price » PKI Stock News

Perkin Elmer Share News

 Perkinelmer, Inc. Stock Price
PKI Stock Price
 Perkinelmer, Inc. Stock Chart
PKI Stock Chart
 Perkinelmer, Inc. Stock News
PKI Stock News
 Perkinelmer, Inc. Company Information
PKI Company Information
 Perkinelmer, Inc. Stock Trades
PKI Stock Trades

PerkinElmer Isn't For Sale, CEO Says; Shares Slide

By Caitlin Nish Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- PerkinElmer Inc. (PKI) isn't for sale, its chief executive said Friday, disputing reports that sent its stock up 6.9% Thursday. "Media reports containing speculation to the effect that PerkinElmer is for sale, or positioning itself for sale, are inaccurate," CEO Robert Friel said in a statement. "A sale of the company is not being discussed, and such a transaction is not in the company's strategic plans." Shares of PerkinElmer, which sells analytical products and services to the health-care and industrial sectors, slid 3.6% in recent trading to $26.72. They are up 19% in the past year. Friel was responding to reports Thursday suggesting the company was considering pursuing a large acquisition or putting itself up for sale after making an unsuccessful attempt for medical-test maker Beckman Coulter Inc. (BEC). Danaher Corp. (DHR) earlier this month agreed to acquire Beckman Coulter for $5.87 billion, ending two months of speculation about the future of Beckman, which endured a rough year last year following the recall of a faulty test for heart problems, multiple financial-guidance cuts and an unexpected CEO resignation. "We continue to be on strategy with regard to our plans for growth, and we remain in strong financial health," Friel said. "PerkinElmer remains committed to growing our business and leveraging the strong foundation we've already built to achieve future growth," he added. PerkinElmer reported at the beginning of this month that its fourth-quarter earnings soared as it booked a $315.3 million gain on the disposition of discontinued operations. It saw growth in both its environmental-health division and human-health division, with revenue up 8% and 12%, respectively. -By Caitlin Nish, Dow Jones Newswires; 212-416-2076; --Jon Kamp and Lauren Pollock contributed to this article.

Stock News for Perkin Elmer (PKI)
03/21/201716:06:49Statement of Changes in Beneficial Ownership (4)
03/15/201716:12:55Statement of Changes in Beneficial Ownership (4)
03/15/201716:12:29Statement of Changes in Beneficial Ownership (4)
03/08/201708:03:40Additional Proxy Soliciting Materials (definitive) (defa14a)
03/08/201708:02:17Proxy Statement (definitive) (def 14a)
02/28/201718:43:06Annual Report (10-k)
02/22/201716:07:11Statement of Changes in Beneficial Ownership (4)
02/21/201716:06:40Statement of Changes in Beneficial Ownership (4)
02/16/201716:15:00Perkinelmer to Present at Barclays Capital Global Healthcare...
02/16/201716:07:43Statement of Changes in Beneficial Ownership (4)
02/13/201717:31:22Amended Statement of Ownership (sc 13g/a)
02/13/201715:13:31Statement of Ownership (sc 13g)
02/10/201716:30:49Statement of Changes in Beneficial Ownership (4)
02/10/201716:14:46Amended Statement of Ownership (sc 13g/a)
02/10/201716:07:50Statement of Changes in Beneficial Ownership (4)
02/08/201718:00:34Statement of Changes in Beneficial Ownership (4)
02/08/201717:39:20Statement of Changes in Beneficial Ownership (4)
02/08/201717:34:59Statement of Changes in Beneficial Ownership (4)
02/08/201717:34:59Statement of Changes in Beneficial Ownership (4)
02/08/201717:28:28Statement of Changes in Beneficial Ownership (4)

Perkin Elmer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations